Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 from the history.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page history.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page history shows a new revision tag (v3.4.2) added and the prior government funding notices removed; these are minor site-wide changes and do not affect trial data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedA new government funding lapse notice appears at the top of the page, indicating information may not be up to date and directing users to opm.gov for status. The site revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check69 days agoChange DetectedThe history page now includes a glossary, color-coded change indicators (green for additions and red for deletions), and updated revision notes showing Revision: v3.4.0 (replacing v3.3.4). It also updates the No FEAR Act Data references accordingly.SummaryDifference0.3%

- Check76 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 in the page history. No other content changes are visible.SummaryDifference0.0%

Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.